Delivery Order SPE2DB22D1017-SPE2DB24FG2ZB
Award Date
8/9/24
Potential Completion Date
8/12/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The $10,203.36 firm fixed-price delivery order is for the supply of 4,565,425,884 units of Carvedilol Extended Release 40 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol Extended-Release 10 mg capsules. The firm-fixed price delivery order has a ceiling value of $21,093.37 and is set to expire on August 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award, valued at $1,568.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol Extended-Release 10 mg capsules, a cardiovascular medication, to support federal healthcare programs. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $7,525.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Carvedilol Extended-Release (ER) 10 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of May 30, 2024 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. In...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,066.14 firm fixed-price delivery order is for the supply of Carvedilol ER 10 mg capsules, a cardiovascular medication. The contract has a completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,617.82 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 10 mg capsules. The contract has a ceiling value of $4,346.65 and an ultimate completion date of January 27, 2025. It is a firm fixed-price delivery order contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract has a firm fixed price of $22,442.54 and an ultimate completion date of August 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,507.61 delivery order contract is for the supply of Carvedilol ER 10 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed price agreement. This award is part of a larger $999,999,999 Indefinite...
This federal contract award, valued at $23,197.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Carvedilol ER 10 mg capsules, a medication used to treat heart conditions. The award is a Firm Fixed Price Delivery Order without any set-aside designation. It has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...